Fexofenadine HCl 180 mg / pseudoephedrine HCl 240 mg 24HR Extended Release Oral Tablet
RxNorm 997415
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 997415 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: fexofenadine HCl 180 mg / pseudoephedrine HCl 240 mg 24HR Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
24 HR fexofenadine hydrochloride 180 mg / pseudoephedrine hydrochloride 240 mg Extended Release Oral Tablet
(Atom ID: 12348815)
PSNPrescribable
Prescribable Name (PSN):
Fexofenadine HCl 180 mg / pseudoephedrine HCl 240 mg 24HR Extended Release Oral Tablet
(Atom ID: 6367251)
SYPrescribable
Synonym (SY):
Fexofenadine hydrochloride 180 mg / pseudoephedrine hydrochloride 240 mg 24 HR Extended Release Oral Tablet
(Atom ID: 11838820)
Patient Education
Fexofenadine and Pseudoephedrine
The combination of fexofenadine and pseudoephedrine is used in adults and children 12 years of age and older to relieve the allergy symptoms of seasonal allergic rhinitis ('hay fever'), including runny nose; sneezing; congestion (stuffy nose); red, itchy, or watery eyes; or itching of the nose, throat, or roof of the mouth. Fexofenadine is in a class of medications called antihistamines. It works by blocking the effects of histamine, a substance in the body that causes allergy symptoms. Pseudoephedrine is in a class of medications called decongestants. It works by drying up the nasal passages.
[Learn More]
* Please review the disclaimer below.